InvestorsHub Logo
Followers 0
Posts 12
Boards Moderated 0
Alias Born 10/15/2009

Re: 4jim post# 5099

Wednesday, 11/18/2009 8:56:24 PM

Wednesday, November 18, 2009 8:56:24 PM

Post# of 59551
If no FDA approval...

There's 2 interesting scenarios. There's the catastrophic flat out denial of approval (HIGHLY unlikely). In that case 3 cents here we come.

Then, there's the possibility of a re-submit. In the short term this will cause mass panic and a sizable drop in share price since a whole heck of a lot of people will lose patience at that time and jump ship. Would probably be a correction into the 50-70 cent range in that case...which is around where the stock price was before Dean's last cc.

The interesting scenario above would be scenario 2, the re-submit. If that is the case, would we get another big run-up like we did now? If so, that would be a huge opportunity for some serious profits (well, at least for those who were wise enough to pull out a big chunk with the recent run-up).

And one last hypothetical is what if no FDA approval for months? As holders of NEPH can attest, the FDA certainly moves at a snail's pace. And to think a decision for IMGG is right around the corner may not be the case. The longer it takes the FDA, the lower the pps will go. That's just a disaster.

Hopefully the FDA will make a decision within the next 3 weeks. If not, it's going to get ugly.